FDA rejects MDMA therapy for treatment of PTSD. What’s next?
MDMA came close to becoming medicine on Friday, but it missed the mark. The Food and Drug Administration declined to approve what would have been the first psychedelic drug used for the treatment of post-traumatic stress disorder, a blow to advocates who have touted the potential of the Schedule I controlled substance also known as
MDMA came close to becoming medicine on Friday, but it missed the mark. The Food and Drug Administration declined to approve what would have been the first psychedelic drug used for the treatment of post-traumatic stress disorder, a blow to advocates who have touted the potential of the Schedule I controlled substance also known as […]
The post FDA rejects MDMA therapy for treatment of PTSD…
Read More
About Author
